1. Synthesis and Biological Evaluation of 1,3,4-Trisubstituted pyrazole Analogues as Anti-mycobacterial Agents. Alegaon, S.G., M.B. Hirpara, K.R. Alagawadi, S.S. Jalalpure, V.P. Rasal, P.S. Salve, and V.M. Kumbar. Medicinal Chemistry Research, 2017. 26(6): p. 1127-1138. ISI[000400365900006].
[WOS]. TB_05_2017.
2. 2-(5-Chlorobenzo[d]thiazol-2-ylimino)thiazolidin-4-one Derivatives as an Antimicrobial Agent. B'Bhatt, H. and S. Sharma. Arabian Journal of Chemistry, 2017. 10: p. S531-S538. ISI[000399414100073].
[WOS]. TB_05_2017.
3. Library Design, Synthesis and Biological Exploration of Novel 3,4'-Bicarbostyril Derivatives as Potent Antimicrobial, Antitubercular and Antimalarial Agents. Jardosh, H.H., N.D. Vala, and M.P. Patel. Medicinal Chemistry Research, 2017. 26(5): p. 881-899. ISI[000399237300002].
[WOS]. TB_05_2017.
4. Transition Metal Complexes of 2-(2-(1H-Benzo[d]imidazol-2-yl)hydrazono)propan-1-ol: Synthesis, Characterization, Crystal Structures and Anti-tuberculosis Assay with Docking Studies. Kamat, V., D. Kokare, K. Naik, A. Kotian, S. Naveen, S.R. Dixit, N.K. Lokanath, S.D. Joshi, and V.K. Revankar. Polyhedron, 2017. 127: p. 225-237. ISI[000400211800023].
[WOS]. TB_05_2017.
5. Combinations of Avibactam and Carbapenems Exhibit Enhanced Potencies against Drug-resistant Mycobacterium abscessus. Kaushik, A., C. Gupta, S. Fisher, E. Story-Roller, C. Galanis, N. Parrish, and G. Lamichhane. Future Microbiology, 2017. 12: p. 473-480. PMID[28326811].
[PubMed]. TB_05_2017.
6. Design, Characterization, in Vitro Antibacterial, Antitubercular Evaluation and Structure-Activity Relationships of New Hydrazinyl thiazolyl coumarin Derivatives. KhanYusufzai, S., H. Osman, M.S. Khan, S. Mohamad, O. Sulaiman, T. Parumasivam, J.A. Gansau, N. Johansah, and Noviany. Medicinal Chemistry Research, 2017. 26(6): p. 1139-1148. ISI[000400365900007].
[WOS]. TB_05_2017.
7. Efficient Synthesis and Biological Evaluation of New Benzopyran-annulated Pyrano[2,3-c]pyrazole Derivatives. Labana, B.M., G.C. Brahmbhatt, T.R. Sutariya, N.J. Parmar, J.M. Padron, R. Kant, and V.K. Gupta. Molecular Diversity, 2017. 21(2): p. 339-354. PMID[28293833].
[PubMed]. TB_05_2017.
8. Octahedral Ruthenium(II) polypyridyl Complexes as Antimicrobial Agents against Mycobacterium. Liao, G.J., Z.Y. Ye, Y.L. Liu, B. Fu, and C. Fu. PeerJ, 2017. 5: e3252. PMID[28462049]. PMCID[PMC5410163].
[PubMed]. TB_05_2017.
9. Synthesis and Pharmacological Studies of 1-(2-Amino-1-(4-methoxyphenyl) ethyl) cyclohexanol Analogs as Potential Microbial Agents. Mahyavanshi, V., S.I. Marjadi, and R. Yadav. Arabian Journal of Chemistry, 2017. 10: p. S804-S813. ISI[000399414100108].
[WOS]. TB_05_2017.
10. Synthesis and Antitubercular Evaluation of Imidazo[2,1-b][1,3,4]thiadiazole Derivatives. Patel, H.M., M.N. Noolvi, N.S. Sethi, A.K. Gadad, and S.S. Cameotra. Arabian Journal of Chemistry, 2017. 10: p. S996-S1002. ISI[000399414100131].
[WOS]. TB_05_2017.
11. Synthesis, Spectral, Biological Activity, and Crystal Structure Evaluation of Novel Pyrazoline Derivatives Having Sulfonamide Moiety. Sadashiva, R., D. Naral, J. Kudva, N. Shivalingegowda, N.K. Lokanath, and K.J. Pampa. Medicinal Chemistry Research, 2017. 26(6): p. 1213-1227. ISI[000400365900014].
[WOS]. TB_05_2017.
12. Three-component, One-pot Synthesis of Anthranilamide Schiff Bases Bearing 4-Aminoquinoline Moiety as Mycobacterium tuberculosis Gyrase Inhibitors. Salve, P.S., S.G. Alegaon, and D. Sriram. Bioorganic & Medicinal Chemistry Letters, 2017. 27(8): p. 1859-1866. PMID[28274627].
[PubMed]. TB_05_2017.
13. Thiazomycin, Nocathiacin and Analogs Show Strong Activity against Clinical Strains of Drug-resistant Mycobacterium tuberculosis. Singh, S.B., L. Xu, P.T. Meinke, N. Kurepina, B.N. Kreiswirth, D.B. Olsen, and K. Young. The Journal of Antibiotics, 2017. 70(5): p. 671-674. PMID[28096545].
[PubMed]. TB_05_2017.
14. 1,5-Diarylpyrroles as Potent Antitubercular and Anti-inflammatory Agents. Venditti, G., G. Poce, S. Consalvi, and M. Biava. Chemistry of Heterocyclic Compounds, 2017. 53(3): p. 281-291. ISI[000400545300005].
[WOS]. TB_05_2017.
15. Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure-Activity Relationships and Membrane Targeting Properties. Yang, T.M., W. Moreira, S.A. Nyantakyi, H. Chen, D.B. Aziz, M.L. Go, and T. Dick. Journal of Medicinal Chemistry, 2017. 60(7): p. 2745-2763. PMID[28290692].
[PubMed]. TB_05_2017.
16. Antituberculosis Agents Bearing the 1,2-Disubstituted benzimidazole Scaffold. Yeong, K.Y., C.W. Ang, M.A. Ali, H. Osman, and S.C. Tan. Medicinal Chemistry Research, 2017. 26(4): p. 770-778. ISI[000399236900006].
[WOS]. TB_05_2017.
17. Madurastatin B3, a Rare Aziridine Derivative from Actinomycete Nocardiopsis sp LS150010 with Potent Anti-tuberculosis Activity. Zhang, X.J., H.T. He, R. Ma, Z.C. Ji, Q. Wei, H.Q. Dai, L.X. Zhang, and F.H. Song. Journal of Industrial Microbiology & Biotechnology, 2017. 44(4-5): p. 589-594. PMID[28181080].
[PubMed]. TB_05_2017.
18. Discovery of Fluorine-containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis. Zhao, H., Y. Lu, L. Sheng, Z. Yuan, B. Wang, W. Wang, Y. Li, C. Ma, X. Wang, D. Zhang, and H. Huang. ACS Medicinal Chemistry Letters, 2017. 8(5): p. 533-537. PMID[28523106]. PMCID[PMC5430409].
[PubMed]. TB_05_2017.
Patent Citations
19. Peptides from Scorpion Vaejovis punctatus as Antibiotics against Mycobacterium tuberculosis and Further Pathogen Bacteria and Yeasts. Corzo Burguete, G.A., L.D. Possani Postay, E. Ortiz Suri, S. Ramirez Carreto, J.M. Jimenez Vargas, and B. Becerril Lujan. Patent. 2017. 2015-8582 2015008582: 43pp.
[Patent]. TB_05_2017.
20. Pharmaceutical Composition, Use of Mefloquine in a Fixed Dose, and Method for Treating Tuberculosis. De Souza, M.V.N., R.S.B. Goncalves, and M.C.d.S. Lourenco. Patent. 2017. 2016-BR50254 2017070763: 25pp.
[Patent]. TB_05_2017.
21. Compositions and Methods for Treating Bacterial Infections. Perkins, W., V. Malinin, F. Leifer, C. Figueroa, and K. Dipetrillo. Patent. 2017. 2016-US62894 2017087876: 77pp.
[Patent]. TB_05_2017.